TEAM Stock Analysis: Atlassian | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 39.395m USD | 12M Return: -3.7% | US0494681010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 557M
EPS Trend: 80.7%
Qual. Beats: 5
Rev. Trend: 99.8%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 10.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Atlassian Corporation is a collaboration software provider that helps organizations connect teams and improve productivity at scale. Its product suite spans project management (Jira), team collaboration and knowledge sharing (Confluence), asynchronous video communication (Loom), IT and HR service management (Jira Service Management), and AI-powered workflows (Rovo). The company also offers developer-focused tools such as Bitbucket, Compass, and Jira Align, as well as productivity and security applications including Trello and Guard.
The company was founded in 2002 and is headquartered in Sydney, Australia, while trading on the NASDAQ as a U.S.-listed ADR. It generates revenue primarily through a subscription-based, seat-licensed software model that targets both large enterprises and smaller teams, operating within the Application Software sub-industry of the broader Information Technology sector. A notable strategic partnership with Mattermost supports the development of a sovereign, self-hosted successor to Confluence for defense, intelligence, and critical infrastructure clients, reflecting the firms expansion into regulated and security-sensitive markets.
- Cloud subscription ARR growth fuels top-line expansion
- Rovo AI adoption drives enterprise seat expansion
- Microsoft Azure DevOps competition pressures Jira share
| Net Income: -53.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.22 > 0.02 and ΔFCF/TA -1.82 > 1.0 |
| NWC/Revenue: -11.78% < 20% (prev 13.62%; Δ -25.40% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.35b > Net Income -53.8m |
| Net Debt (247.3m) to EBITDA (151.0m): 1.64 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.4m) vs 12m ago -3.61% < -2% |
| Gross Margin: 84.83% > 18% (prev 82.84%; Δ 1.99% > 0.5%) |
| Asset Turnover: 108.2% > 50% (prev 86.32%; Δ 21.91% > 0%) |
| Interest Coverage Ratio: 0.21 > 6 (EBIT TTM 10.4m / Interest Expense TTM 49.5m) |
| A: -0.13 (Total Current Assets 2.80b - Total Current Liabilities 3.57b) / Total Assets 6.10b |
| B: -1.00 (Retained Earnings -6.11b / Total Assets 6.10b) |
| C: 0.00 (EBIT TTM 10.4m / Avg Total Assets 6.07b) |
| D: 0.21 (Book Value of Equity 1.06b / Total Liabilities 5.05b) |
| Altman-Z'' = -3.86 = D |
| DSRI: 1.29 (Receivables 1.27b/778.3m, Revenue 6.57b/5.22b) |
| GMI: 0.98 (GM 82.84% / 84.83%) |
| AQI: 1.64 (AQ_t 0.51 / AQ_t-1 0.31) |
| SGI: 1.26 (Revenue 6.57b / 5.22b) |
| TATA: -0.23 (NI -53.8m - CFO 1.35b) / TA 6.10b) |
| Beneish M = -2.26 (Cap -4..+1) = BBB |
As of August 19, 2026, the stock is trading at USD 163.00 with a total of 4,741,344 shares traded. Over the past week, the price has changed by +5.79%, over one month by +69.03%, over three months by +82.26% and over the past year by -3.65%.
Current recommended Stop Loss: 152.20 (which is 6.6% or 1.2 ATR below the current price).
Atlassian has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy TEAM.
- StrongBuy: 19
- Buy: 7
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 188.2 | 15.5% |
P/E Forward = 24.2718
P/S = 5.9941
P/B = 36.4118
P/EG = 1.213
Revenue TTM = 6.57b USD
EBIT TTM = 10.4m USD
EBITDA TTM = 151.0m USD
Long Term Debt = 989.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 48.5m USD (from shortTermDebt, last quarter)
Debt = 1.49b USD (from shortLongTermDebtTotal, last quarter) + Leases 253.9m
Net Debt = 247.3m USD (calculated: Debt 1.49b - CCE 1.24b)
Enterprise Value = 39.6b USD (39.4b + Debt 1.49b - CCE 1.24b)
Interest Coverage Ratio = 0.21 (Ebit TTM 10.4m / Interest Expense TTM 49.5m)
EV/FCF = 30.05x (Enterprise Value 39.6b / FCF TTM 1.32b)
FCF Yield = 3.33% (FCF TTM 1.32b / Enterprise Value 39.6b)
FCF Margin = 20.07% (FCF TTM 1.32b / Revenue TTM 6.57b)
Net Margin = -0.82% (Net Income TTM -53.8m / Revenue TTM 6.57b)
Gross Margin = 84.83% ((Revenue TTM 6.57b - Cost of Revenue TTM 996.8m) / Revenue TTM)
Gross Margin QoQ = 86.88% (prev 84.92%)
Tobins Q-Ratio = 6.49 (Enterprise Value 39.6b / Total Assets 6.10b)
Interest Expense / Debt = 3.33% (Interest Expense 49.5m / Debt 1.49b)
Taxrate = 29.38% (57.8m / 196.9m)
NOPAT = 7.31m (EBIT 10.4m * (1 - 29.38%))
Current Ratio = 0.78 (Total Current Assets 2.80b / Total Current Liabilities 3.57b)
Debt / Equity = 1.40 (Debt 1.49b / totalStockholderEquity, last quarter 1.06b)
Debt / EBITDA = 1.64 (Net Debt 247.3m / EBITDA 151.0m)
Debt / FCF = 0.19 (Net Debt 247.3m / FCF TTM 1.32b)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.89% (Net Income -53.8m / Total Assets 6.10b)
RoE = -4.39% (Net Income TTM -53.8m / Total Stockholder Equity 1.23b)
RoCE = 0.47% (EBIT 10.4m / Capital Employed (Equity 1.23b + L.T.Debt 989.1m))
RoIC = 0.32% (NOPAT 7.31m / Invested Capital 2.25b)
WACC = 11.03% (E(39.4b)/V(40.9b) * Re(11.36%) + D(1.49b)/V(40.9b) * Rd(3.33%) * (1-Tc(0.29)))
Discount Rate = 11.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -32.07 | Cagr: -1.44%
[DCF] Terminal Value 65.44% ; FCFF base≈1.36b ; Y1≈1.29b ; Y5≈1.21b
[DCF] Fair Price = 80.94 (EV 13.2b - Net Debt 247.3m = Equity 12.9b / Shares 159.6m; r=11.03% [WACC]; 5y FCF grow -6.81% → 2.50% )
EPS Correlation: 80.69 | EPS CAGR: 19.54% | SUE: 2.73 | # QB: 5
Revenue Correlation: 99.79 | Revenue CAGR: 22.15% | SUE: 3.12 | # QB: 4
EPS current Quarter (2026-09-30): EPS=1.42 | Chg30d=+10.44% | Revisions=-67% | Analysts=26
EPS next Quarter (2026-12-31): EPS=1.30 | Chg30d=-12.94% | Revisions=-67% | Analysts=27
EPS current Year (2027-06-30): EPS=5.42 | Chg30d=-12.74% | Revisions=-56% | GrowthEPS=-7.3% | GrowthRev=+13.4%
EPS next Year (2028-06-30): EPS=6.76 | Chg30d=-7.37% | Revisions=-18% | GrowthEPS=+24.8% | GrowthRev=+15.1%
[Analyst] Revisions Ratio: -65% (up=7, down=38)